rticles or if the solution is not clear.
The contents of a vial should be used immediately after piercing of the rubber stopper.
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.
7. Marketing authorisation holder
Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon
Hertfordshire EN11 9BU
United Kingdom
8. Marketing authorisation number(s)
Puregon 50 IU/0.5 ml solution for injection
EU/1/96/008/17
EU/1/96/008/18
EU/1/96/008/19
Puregon 100 IU/0.5 ml solution for injection
EU/1/96/008/23
EU/1/96/008/24
EU/1/96/008/25
9. Date of first authorisation/renewal of the authorisation
Date of first authorisation: 03 May 1996
Date of latest renewal: 03 May 2006
10. Date of revision of the text
20 February 2014
11. Legal category
Prescription Only Medicine
Detailed information on this product is available on the website of the European Medicines Agency http://www.ema.europa.eu